Li, Ao – Trademark Portfolio
Entity Type: 01
Li, Ao owns a portfolio of 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as YUNCE, FEYWAY, FRIFUN, EVAFOOR, and YUFUTOL. Of these, 6 are registered. The portfolio spans 6 Nice Classification classes, led by Class 9 (Computers & Electronics) and Class 25 (Clothing). Headquartered in Liaoning Province.
No. 13-100,Yuanlin Road,
Tiedong District,Anshan City,
Liaoning Province 114001 , CN
Showing of trademarks Trademarks
Trademark Classifications
Li, Ao's trademark portfolio spans 6 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Leather and imitations of leather; animal skins, hides; trunks and travelling bags
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Games and playthings; gymnastic and sporting articles; decorations for Christmas trees
Frequently Asked Questions
How many trademarks does Li, Ao have?
Li, Ao has 10 U.S. trademarks filed with the USPTO. Of these, 6 registered, 2 abandoned, 2 cancelled.
What trademark classes does Li, Ao file in?
Li, Ao files trademarks across 6 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 25 (Clothing), Class 8 (Hand Tools), Class 18 (Leather Goods), Class 5 (Pharmaceuticals). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are Li, Ao's most well-known trademarks?
Li, Ao's registered trademark portfolio includes well-known marks such as YUNCE, FEYWAY, FRIFUN, EVAFOOR, and YUFUTOL. These are among 6 currently registered trademarks in the portfolio.
What is Li, Ao's trademark registration success rate?
Li, Ao has a 60% trademark registration rate, with 6 out of 10 resolved applications resulting in successful registration. Currently, 0 applications are pending review.